Interim Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Apr. 01, 2022	Sep. 24, 2021
Current assets:
Cash and cash equivalents	$ 900,393	$ 1,225,380
Restricted cash	8,445	7,652
Short-term investments	141,688	38,839
Accounts receivable, net of allowance for credit losses of $10,156 and $8,744	227,263	232,609
Contract assets, net of allowance for credit losses of $125 and $208	258,846	182,316
Inventories, net	16,623	10,965
Prepaid expenses and other current assets	68,312	62,737
Total current assets	1,621,570	1,760,498
Long-term investments	124,142	62,819
Property, plant and equipment, net	527,623	534,381
Operating lease right-of-use assets	58,934	67,128
Intangible assets, net	126,281	122,890
Goodwill	371,738	340,694
Other non-current assets	57,464	61,257
Deferred taxes	175,238	156,020
Total assets	3,062,990	3,105,687
Current liabilities:
Accounts payable	11,373	17,779
Accrued liabilities	228,545	262,728
Income taxes payable	3,519	1,334
Contract liabilities	22,109	18,473
Operating lease liabilities	15,413	15,403
Total current liabilities	280,959	315,717
Non-current contract liabilities	24,569	23,713
Non-current operating lease liabilities	48,191	56,715
Other non-current liabilities	104,083	105,310
Total liabilities	457,802	501,455
Stockholders’ equity:
Retained earnings	2,615,354	2,607,909
Accumulated other comprehensive loss	(15,681)	(10,030)
Total stockholders’ equity – Dolby Laboratories, Inc.	2,599,772	2,597,979
Controlling interest	5,416	6,253
Total stockholders’ equity	2,605,188	2,604,232
Total liabilities and stockholders’ equity	3,062,990	3,105,687
Class A, $0.001 par value, one vote per share, 500,000,000 shares authorized: 64,789,579 shares issued and outstanding at April 1, 2022 and 64,986,316 at September 24, 2021
Stockholders’ equity:
Common stock	58	59
Class B, $0.001 par value, ten votes per share, 500,000,000 shares authorized: 36,086,629 shares issued and outstanding at April 1, 2022 and 36,086,779 at September 24, 2021
Stockholders’ equity:
Common stock	$ 41	$ 41